TY - JOUR T1 - Effect of COVID 19 restrictive measures on tobacco, cigarette or e-cigarette consumption JF - European Respiratory Journal JO - Eur Respir J DO - 10.1183/13993003.congress-2021.PA3201 VL - 58 IS - suppl 65 SP - PA3201 AU - Ioannis C Lampropoulos AU - Foteini Malli AU - Iias Dimeas AU - Dimitrios Raptis AU - Garyfallia Perlepe AU - Zoe Daniil AU - Konstantinos I Gourgoulianis Y1 - 2021/09/05 UR - http://erj.ersjournals.com/content/58/suppl_65/PA3201.abstract N2 - Introduction: The negative effects of smoking are causally associated with a variety of respiratory diseases. Smoking also damages the immune system and its response to infections, making smokers more vulnerable to infectious diseases.Aim: In the present study, the effect of restrictive measures on the consumption of tobacco, cigarettes and ml e-cigarettes was studied.Methods: The present study was implemented during the period 10/04/2020 - 02/05/2020 in Greece through the sharing of an electronic questionnaire answered by 200 smokers or vapers. The statistical analysis was performed with the statistical program SPSS 22.Results: Of the participants, 62.5% were women and 37.5% were men. Most smokers - vapers belonged to the age group 36-45 years. Most smokers, smoked > 10 years and most vapers 2-5 years. We recorded that 20% were new smokers and new vapers (<1 year). The average daily consumption of cigarettes before the restrictive measures was 15.06 ± 9.842 cigarettes, and during the quarantine 14.52 ± 10.13 cigarettes. Respectively, the average daily consumption of vapers was 0.54 ml before the onset of the restrictions, and 0.61 ml during the quarantine. On average, women smoke more cigarettes than men. Vaporization increased after the onset of the restrictive mneasures in men.Conclusions: Based on our findings, the effect of the restrictive measures led to an increase in ml of vaporization while smoking remained stable.FootnotesCite this article as: European Respiratory Journal 2021; 58: Suppl. 65, PA3201.This abstract was presented at the 2021 ERS International Congress, in session “Prediction of exacerbations in patients with COPD”.This is an ERS International Congress abstract. No full-text version is available. Further material to accompany this abstract may be available at www.ers-education.org (ERS member access only). ER -